Medicare & Medicaid
News articles in this section include actions by federal regulators like the CMS and HHS, as well as information on Medicare and state Medicaid coverage and benefits.
Health insurance companies are calling on Congress to provide more funding to help people keep coverage, citing the more than 44 million who have filed for unemployment since the coronavirus crisis started.
HHS on Friday announced plans to send an additional $3 billion in provider COVID-19 relief grants to safety-net hospitals that were left out of a prior funding tranche, and will give $1 billion to an assortment of rural and smaller hospitals.
CMS Administrator Seema Verma: The Centers for Medicare and Medicaid Services needs help from Congress to make temporary flexibilities permanent.
Nevada lawmakers have started cleaning up a ten-figure budget mess caused by the coronavirus, opening a special legislative session on Wednesday that will see hundreds of millions of dollars slashed from the state’s $4.4 billion annual spending plan.
Coverage options for furloughed workers and laid off individuals who do not have an employer-sponsored plan illuminate the instability of healthcare tied to employment.
A health insurer backed by Google’s venture capital affiliate says it has raised $225 million more funding.
Cynthia Peeters' stomach started hurting in mid-February as COVID-19 began dominating the news. By April, the pain was overwhelming, but she was too anxious about the virus to go to the doctor.
Once a hot topic in American politics, drug prices have taken a back seat to the COVID-19 pandemic and conversations around racial injustice nationwide. In the midst of all that, though, Sen. Chuck Grassley, R-Iowa, has still been pushing for drug pricing legislation. But his effort now seems to be losing steam.
House Democrats on Monday passed a bill that would bolster the Affordable Care Act by hiking premium subsidies and incentivizing states to expand Medicaid.
The chairman of the influential Senate Finance Committee will push for a vote on his drug-pricing measure without the help of critical allies: Senate Democrats.